Quest Diagnostics: Diagnostic Specialist Benefits from Rising Treatment Numbers and New AI Tools for Cancer Detection!
Reading Time: 1 minute
Growth Driver: Quest Diagnostics (DGX) is one of the world's leading providers of clinical testing and diagnostic procedures. In addition to standard blood tests and diagnostic methods for detecting civilization diseases such as diabetes or genetic disorders, they have significantly strengthened their market position in testing procedures for infectious diseases (hepatitis, AIDS, Lyme disease, tuberculosis) as well as in cardiovascular diseases and oncology, especially due to the acquisition of PathAI Diagnostic, where considerable progress has...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
